About us

phar­mafakt has been sup­por­ting doc­tors” and phar­macists” pro­fes­sio­nal asso­cia­ti­ons, uni­ver­si­ty rese­arch and the phar­maceu­ti­cal indus­try sin­ce 1998 with com­pre­hen­si­ve, dif­fe­ren­tia­ted and fun­da­ment­al­ly data-backed stu­dies and ana­ly­ses as well as pro­ven con­sul­ting exper­ti­se on all issu­es in the drugs mar­ket.

phar­mafakt’s share­hol­ders inclu­de the phar­macists” asso­cia­ti­ons of the federal sta­tes of Bava­ria, Baden-Württemberg and Sax­o­ny (SASG), NOVENTI GmbH, a lea­der in pro­duc­ts and ser­vices in natio­nal and inter­na­tio­nal health in Munich, and ARZ-Holdinggesellschaft für Soft­ware­in­no­va­tio­nen mbH (an ARZ-Haan AG com­pa­ny).

The phar­mafakt con­sul­ting con­cept is based on data obtai­ned in data pro­ces­sing cen­tres for phar­maci­es during pre­scrip­ti­on sett­le­ment. This data is anony­mi­sed and made avail­ab­le to a spe­cial trust cent­re.

The­re, the data is pro­ces­sed on behalf of phar­mafakt on a project-specific basis and in a cus­to­mi­sed way to crea­te sta­tis­tics and ana­ly­ses which are then avail­ab­le for our uni­que, indi­vi­du­al and data-backed con­sul­ting exper­ti­se.


We call this data-backed phar­ma con­sul­ting.
The inno­va­ti­ve phar­mafakt con­cept - a tailo­red business-to-business part­nership